Edwards Lifesciences (EW) news
Recent news
Edwards Lifesciences shares open 6.5% higher after 2Q results
AInvest Wire · Jul 24, 2026Raymond James raises target price to $103 from $100 for Edwards Lifesciences Corp
AInvest Wire · Jul 24, 2026Edwards raised to outperform from market perform at Leerink
Leerink has upgraded Edwards Lifesciences to "outperform" from "market perform," reflecting a positive shift in the firm's outlook for the medical technology company. The adjustment follows recent developments in Edwards' portfolio and market positioning, which Leerink believes position the company…
AInvest Wire · Jul 24, 2026JPMorgan raised its price target on Edwards Lifesciences Corp. to $105, up from the previous target of $100.
JPMorgan has raised its price target for Edwards Lifesciences Corp. (NYSE: EW) to $105, an increase from the prior target of $100. The adjustment reflects the firm’s updated assessment of the company’s financial outlook and market positioning. Edwards Lifesciences, a leading developer of medical…
AInvest Wire · Jul 24, 2026Edwards Lifesciences Corp FY2026 SHR view $3.01, rev view $6.75 bln - LSEG IBES data
AInvest Wire · Jul 23, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.